ARCHIVES

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

This article is from The Cancer Letter archive.

Vol. 26 No. 35 | September 29, 2000

Download PDF Visit The Full Archive

Related Articles

12 Minority CCOPs Awardees Names, San Antonio Gets 2

September 21, 1990

IMRT Usage and Cost Related to Geography And Medicare Reimbursement Policy, Study Finds

April 29, 2011

Kennedy, Waxman Disagree On Authorization Issue; Legislation For NIH, NCI This Congress Threatened

September 26, 1980

RFA For Patterns Of Care Study in Elderly Issues

January 14, 1983

Fred Hutchinson Center Wins $140 Mil. Contract To Coordinate NIH Women’s Health Initiative

October 23, 1992

ACS Encourages Grant Applications In All Aspects Of Pain Control

May 7, 1993